Actuate Therapeutics, Inc. (ACTU)
0.9812
-0.01
(-1.41%)
USD |
NASDAQ |
Sep 18, 16:00
0.98
0.00 (0.00%)
After-Hours: 06:14
Actuate Therapeutics Total Liabilities (Quarterly) : 4.210M for June 30, 2026
Total Liabilities (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Total Liabilities (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | 4.210M |
| March 31, 2026 | 5.127M |
| December 31, 2025 | 6.112M |
| September 30, 2025 | 6.778M |
| June 30, 2025 | 9.623M |
| March 31, 2025 | 9.571M |
| Date | Value |
|---|---|
| December 31, 2024 | 9.214M |
| September 30, 2024 | 8.904M |
| June 30, 2024 | 21.81M |
| March 31, 2024 | 16.29M |
| December 31, 2023 | 8.444M |
Total Liabilities Definition
Liabilities are a main portion of the balance sheet of a company that measure outstanding payables/obligations. A few examples of liabilties of a company include accounts payable, current debt, and capital lease obligations. From an accounting perspective, the balance sheet equation is Liabilties = Assets - Shareholder's Equity.
Total Liabilities (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Total Liabilities (Quarterly) Benchmarks
| ACADIA Pharmaceuticals, Inc. | 436.29M |
| Alnylam Pharmaceuticals, Inc. | 4.205B |
| Anika Therapeutics, Inc. | 46.19M |
| Savara, Inc. | 48.48M |
| Vericel Corp. | 132.82M |
Total Liabilities (Quarterly) Related Metrics
| Total Assets (Quarterly) | 5.199M |
| Shareholders Equity (Quarterly) | 0.9892M |
| Debt to Equity Ratio | 0.4094 |
| Current Ratio | 1.248 |